ChipMOS Shanghai Equity Interest Transfer Completed to Tsinghua Unigroup LED Strategic Investors

ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS) announced the completion of its previously disclosed equity interest transfer to a group of investors led by Tsinghua Unigroup ("Strategic Investors").

(Image: ChipMOS)
 
Under the joint-venture agreement approved by the Board of ChipMOS on November 30, 2016, ChipMOS TECHNOLOGIES (BVI) LTD. ("ChipMOS BVI"), a wholly owned subsidiary of ChipMOS, sold 54.98% of the equity interest of its wholly owned subsidiary, ChipMOS TECHNOLOGIES (Shanghai) LTD. ("ChipMOS Shanghai"), to Strategic Investors for approximately US$72 million.
 
ChipMOS BVI will continue to own 45.02% of the equity interests of ChipMOS Shanghai, Tsinghua Unigroup through its subsidiary, Tibet Unigroup Guowei Investment Co., Ltd. ("Unigroup Guowei") will own 48%, and other strategic investors, including a limited partnership owned by ChipMOS Shanghai's employees will own 6.98%. 
 
Upon receipt of the proceeds from the equity interest sale, the Company plans to reinvest back into ChipMOS Shanghai approximately RMB 484 million (approximately US$70 million) pro rata, resulting in the total additional investment of RMB 1,074 million (approximately US$155 million) to ChipMOS Shanghai, which will allow for the expansion of the capacity of and services offered by ChipMOS Shanghai.
 
The reinvestment is expected to occur in two tranches, one by the end of the first half of 2017 and one depending on the CapEx plan of ChipMOS Shanghai, which is directly aligned with the operation's strategic growth plan. 
 
S.J. Cheng, Chairman of ChipMOS, commented, "This is another major step forward that strengthens our competitive position, significantly expands the growth potential of our ChipMOS Shanghai's operations, and creates a higher return for our company and shareholders. We appreciate the confidence expressed by Tsinghhua Unigroup and our other strategic investors in selecting ChipMOS Shanghai as their partner given the expected growth of China's domestic semiconductor supply chain and the critical role OSAT services will play in ensuring higher quality yields and supporting the overall expected expansion." 
 
"With the benefit of the additional financial and strategic partnership resources, we can now further accelerate the planned expansion for LCD driver ICs, touch driver, AMOLED, OLED and memory testing, assembly and bumping services offered by ChipMOS Shanghai.  We look forward to working closely with Tsinghua Unigroup to grow ChipMOS Shanghai's revenue and profit, while promoting the interests of all shareholders and employees," he concluded. 

Disclaimers of Warranties
1. The website does not warrant the following:
1.1 The services from the website meets your requirement;
1.2 The accuracy, completeness, or timeliness of the service;
1.3 The accuracy, reliability of conclusions drawn from using the service;
1.4 The accuracy, completeness, or timeliness, or security of any information that you download from the website
2. The services provided by the website is intended for your reference only. The website shall be not be responsible for investment decisions, damages, or other losses resulting from use of the website or the information contained therein<
Proprietary Rights
You may not reproduce, modify, create derivative works from, display, perform, publish, distribute, disseminate, broadcast or circulate to any third party, any materials contained on the services without the express prior written consent of the website or its legal owner.

Tokushima, Japan - 6 March 2024: Nichia, the world's largest LED manufacturer and inventor of the high-brightness blue and white LED, has started mass production of the new UV-B (308nm) and UV-A (330nm) LEDs in its popular 434 Series packa... READ MORE

New XLamp® S Line LEDs enhance growth, last longer, lower energy costs Horticulture and other forms of agricultural lighting require application-tuned ratios of spectral content, high efficacy and long lifetimes. Whether you are interested... READ MORE